NOVEL USE OF CA-125
Provided is novel use of CA-125. As it is discovered that CA-125 level are positively associated with bone mineral density, thereby CA-125 can be used in biomarker to diagnose osteoporosis or osteopenia, or extent of growth plate development.
1 . A kit for diagnosing osteoporosis or osteopenia, or extent of growth plate development comprising a probe selectively binding to carbohydrate antigen 125 (CA-125).
2 . The kit of claim 1 , wherein the probe is selected from the group consisting of a primer and a nucleic acid probe selectively binding to CA-125.
3 . The kit of claim 1 , wherein the probe is an antibody selectively binding to CA-125.
4 . The kit of claim 1 , wherein the kit is to detect expression of CA-125 either at the nucleic acid or protein level.
5 . A method for diagnosing osteoporosis or osteopenia, or extent of growth plate development in an individual, said method comprising:
contacting a biological sample from said individual with a probe selectively binding to carbohydrate antigen 125 (CA-125) and determining expression of CA-125,
wherein under-expression of the CA-125, relative to a normal control, is indicative of osteoporosis or osteopenia in the individual; or
if the individual is a child and adolescent, increased level of the CA-125 is indicative of increase of the extent of growth plate development.
6 . The method of claim 5 , wherein said biological sample is selected from the group consisting of tissues, cells, blood, serum, plasma, sputum, and urine.
7 . The method of claim 5 , wherein the probe is selected from the group consisting of a primer and a nucleic acid probe selectively binding to CA-125.
8 . The method of claim 5 , wherein the probe is a plurality of antibodies selectively binding to CA-125.
9 . The method of claim 5 , wherein the expression of CA-125 is detected either at the nucleic acid or protein level.